Eden Biosolutions PLC
06 October 2026
Eden BioSolutions plc
("Eden" or the “Company")
Investor presentation
Eden BioSolutions plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, will provide an update to shareholders on the IMC platform, delivering the same presentation that was used at the Company’s AGM on 29 September 2026 on Monday, 12 October 2026 at 2pm.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up 9am the day before, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Eden BioSolutions plc via:
https://www.investormeetcompany.com/eden-biosolutions-plc/register-investor
The presentation is available to view on the Company website here.
For further information contact:
|
Eden BioSolutions plc |
||||||||
|
Sean Smith, Chief Executive Officer |
Via Walbrook PR |
|||||||
|
Alex Abrey, Chief Financial Officer |
|
|||||||
|
|
|
|||||||
|
CavendishCapital Markets Limited(Nominated advisor and joint broker) |
Tel: 020 7220 0500 |
|||||||
|
Giles Balleny/Elysia Bough(Corporate Finance) |
|
|||||||
|
Harriet Ward(Corporate Broking) / Dale Bellis(Sales) |
|
|||||||
|
|
|
|||||||
|
Oberon Capital(Joint Broker) |
Tel: 020 3179 5300 |
|||||||
|
Nick Lovering / Mike Seabrook / Adam Pollock |
|
|||||||
|
|
|
|||||||
|
Walbrook PR (Media Relations & Investor Relations) |
Tel: 020 7933 8780 or eden@walbrookpr.com |
|||||||
|
Paul McManus / Nick Rome / Anna Dunphy |
|
|||||||
Notes to Editors:
Eden BioSolutions plc is the onlyUK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:
Based on plant-derived active ingredients,Mevalone®is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes.It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.
Cedroz™is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.
Eden's seed treatment product (approval expected in 2026),Ecovelexwas developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops.Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources.The product is based on Eden's plant-derived chemistry, registered in the EU, US and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.
Eden'sSustaine®encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.
Eden was admitted to trading on AIM on11 May 2012and trades under the symbol EDEN. It was awarded theLondon Stock ExchangeGreen Economy MarkinJanuary 2021, which recognisesLondon-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.
For more information about Eden, please visit:www.edenresearch.com.
Follow Eden onLinkedIn,TwitterandYouTube.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.